Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 2961-2967

  Jin, Y ^a   Yip, H K ^a   Samaranayake, Y H ^a   Yau, J Y ^a   Samaranayake, L P ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CRYSTAL VIOLET; TETRAZOLIUM; ZIDOVUDINE;

ADULT; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; INTERMETHOD COMPARISON; MICROTITER PLATE ASSAY; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CARRIER STATE; GENTIAN VIOLET; HIV INFECTIONS; HUMANS; OXIDATION-REDUCTION; TETRAZOLIUM SALTS;

CANDIDA; CANDIDA ALBICANS; DNA VIRUSES; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; VIOLA (ANGIOSPERM);

EID: 0038168441     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.2961-2967.2003     Document Type: Article

References (38)

1. Branchini, M. L., M. A. Pfaller, J. Rhine-Chalberg, T. Frempong, and H. D. Isenberg. 1994. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J. Clin. Microbiol. 32:452-456.
2. Buttke, T. M., J. A. McCubrey, and T. C. Owen. 1993. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods 157:233-240.
3. Cory, A. H., T. C. Owen, J. A. Barltrop, and J. G. Cory. 1991. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3:207-212.
4. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
5. Cox, F. 1983. Adherence of Candida albicans to buccal epithelial cells in children and adults. J. Lab. Clin. Med. 102:960-972.
6. Djordjevic, D., M. Wiedmann, and L. A. McLandsborough. 2002. Microtiter plate assay for assessment of Listeria monocytogenes biofilm formation. Appl. Environ. Microbiol. 68:2950-2958.
7. Ferguson, M. M. 1975. Oral mucous membrane markers of internal disease: part II, p. 246-250. In A. E. Dolby (ed.), Oral mucosa in health and disease. Blackwell Scientific Publications, Oxford, United Kingdom.
8. Hawser, S. 1996. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronized C. albicans cells. J. Med. Vet. Mycol. 34:149-152.
9. Hawser, S. P., and L. J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62:915-921.
10. Hentzer, M., G. M. Teitzel, G. J. Balzer, A. Heydorn, S. Molin, M. Givskov, and M. R. Parsek. 2001. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 83:5395-5401.
11. Hodgson, A. E., S. M. Nelson, M. R. Brown, and P. Gilbert. 1995. A simple in vitro model for growth control of bacterial biofilms. J. Appl. Bacteriol. 79:87-93.
12. Kennedy, M. J. 1988. Adhesion and association mechanisms of Candida albicans. Curr. Top. Med. Mycol. 2:731-769.
13. Kennedy, M. J., and P. A. Volz. 1985. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect. Immun. 49:654-663.
14. Kontoyiannis, D. P., and R. E. Lewis. 2002. Antifungal drug resistance of pathogenic fungi. Lancet 359:1135-1144.
15. Kruczak-Filipov, P., and P. Shively. 1992. Gram stain procedure, p. 1.5.1-1.5.18. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 1. American Society for Microbiology, Washington, D.C.
16. Kuhn, D. M., J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70:878-888.
17. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
18. MacFarlane, T. W., and D. K. Mason. 1975. The physiological responsiveness of the oral mucosa: the role of saliva, p. 127-130. In A. E. Dolby (ed.), Oral mucosa in health and disease. Blackwell Scientific Publications, Oxford, United Kingdom.
19. Macura, A. B. 1988. The influence of some antifungal drugs on in vitro adherence of Candida albicans to human buccal epithelial cells. Mycoses 31:71-76.
20. McCarthy, G. M., I. D. Mackie, J. Koval, H. S. Sandhu, and T. D. Daley. 1991. Factors associated with increased frequency of HIV-related oral candidasis. J. Oral Pathol. Med. 20:332-336.
21. Nguyen, M. H., J. E. Peacock, D. C. Tanner, A. J. Morris, M. L. Nguyen, D. R. Snydman, M. M. Wagener, and V. L. Yu. 1995. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch. Intern. Med. 155:2429-2435.
22. Ollert, M. W., C. Wende, M. Gorlich, C. G. McMullan-Vogel, M. Borg-von Zepelin, C. W. Vogel, and H. C. Korting. 1995. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J. Clin. Microbiol. 33:2543-2549.
23. Pereiro, M., Jr., A. Losada, and J. Toribio. 1997. Adherence of Candida albicans strains isolated from AIDS patients. Comparison with pathogenic yeasts isolated from patients without HIV infection. Br. J. Dermatol. 137:76-80.
24. Qureshi, M. N., C. E. Barr, T. Seshamma, J. Reidy, R. J. Pomerantz, and O. Bagasra. 1995. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J. Infect. Dis. 171:190-193.
25. Ramage, G., K. V. Walle, B. L. Wickes, and J. L. López-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
26. Samaranayake, L. P., L. K. Cheung, and Y. H. Samaranayake. 2002. Candidiasis and other fungal diseases of the mouth. Dermatol. Ther. 15:252-270.
27. Samaranayake, L. P., P. L. Fidel, J. R. Naglik, S. P. Sweet, R. Teanpaisan, and M. M. Coogan. 2002. Fungal infections associated with HIV infection. Oral Dis. 8:151-160.
28. Samaranayake, Y. H., L. P. Samaranayake, E. Pow, and N. Beena. 2001. The antifungal effect of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort. J. Clin. Microbiol. 39:3296-3302.
29. Samaranayake, Y. H., L. P. Samaranayake, J. Y. Y. Yau, W. K. Tsang, B. P. K. Cheung, and K. W. S. Yeung. 2003. "Genotypic shuffling" of sequential clones of C. albicans in HIV-infected individuals with and without symptomatic oral candidiasis. J. Med. Microbiol. 52:349-359.
30. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
31. Singh, P. K., M. R. Parsek, E. P. Greenberg, and M. J. Welsh. 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417:552-555.
32. Singh, S., J. D. Sobel, P. Bhargava, D. Boikov, and J. A. Vazquez. 2002. Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy. Clin. Infect. Dis. 35:1066-1070.
33. Sweet, S. P., S. Cookson, and S. J. Challacombe. 1995. Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells. J. Med. Microbiol. 43:452-457.
34. Tellier, R., M. Krajden, G. A. Grigoriew, and L. Campbell. 1992. Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob. Agents Chemother. 36:1619-1625.
35. Tsang, C. S., and L. P. Samaranayake. 1999. Factors affecting the adherence of Candida albicans to human buccal epithelial cells in human immunodeficiency virus infection. Br. J. Dermatol. 141:852-858.
36. Vargas, K., and S. Joly. 2002. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J. Clin. Microbiol. 40:341-350.
37. Vargas, K., S. A. Messer, M. Pfaller, S. R. Lockhart, J. T. Stapleton, J. Hellstein, and D. R. Soll. 2000. Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J. Clin. Microbiol. 38:3595-3607.
38. Wu, T., L. P. Samaranayake, B. Y. Cao, and J. Wang. 1996. In vitro proteinase production by Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotics. J. Med. Microbiol. 44:311-316.